ATE456578T1 - Serpentinetransmembranrezeptoren exprimiert in menschlichem prostatakrebs und ihre verwendungen - Google Patents
Serpentinetransmembranrezeptoren exprimiert in menschlichem prostatakrebs und ihre verwendungenInfo
- Publication number
- ATE456578T1 ATE456578T1 AT00983938T AT00983938T ATE456578T1 AT E456578 T1 ATE456578 T1 AT E456578T1 AT 00983938 T AT00983938 T AT 00983938T AT 00983938 T AT00983938 T AT 00983938T AT E456578 T1 ATE456578 T1 AT E456578T1
- Authority
- AT
- Austria
- Prior art keywords
- steap
- family
- human
- prostate cancer
- expressed
- Prior art date
Links
- 206010060862 Prostate cancer Diseases 0.000 title abstract 3
- 208000000236 Prostatic Neoplasms Diseases 0.000 title abstract 3
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 title abstract 3
- 102000027257 transmembrane receptors Human genes 0.000 title 1
- 108091008578 transmembrane receptors Proteins 0.000 title 1
- 101000628547 Homo sapiens Metalloreductase STEAP1 Proteins 0.000 abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 102000054725 human STEAP1 Human genes 0.000 abstract 2
- 230000003834 intracellular effect Effects 0.000 abstract 2
- 108090000144 Human Proteins Proteins 0.000 abstract 1
- 102000003839 Human Proteins Human genes 0.000 abstract 1
- 108010052285 Membrane Proteins Proteins 0.000 abstract 1
- 102000018697 Membrane Proteins Human genes 0.000 abstract 1
- 102100026712 Metalloreductase STEAP1 Human genes 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 108091077778 STEAP family Proteins 0.000 abstract 1
- 102000042326 STEAP family Human genes 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 210000002307 prostate Anatomy 0.000 abstract 1
- 210000005267 prostate cell Anatomy 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Pathology (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Reproductive Health (AREA)
- Toxicology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Gastroenterology & Hepatology (AREA)
- Food Science & Technology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/455,486 US6833438B1 (en) | 1999-06-01 | 1999-12-06 | Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| PCT/US2000/033040 WO2001040276A2 (en) | 1999-12-06 | 2000-12-06 | Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE456578T1 true ATE456578T1 (de) | 2010-02-15 |
Family
ID=23809010
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00983938T ATE456578T1 (de) | 1999-12-06 | 2000-12-06 | Serpentinetransmembranrezeptoren exprimiert in menschlichem prostatakrebs und ihre verwendungen |
Country Status (12)
| Country | Link |
|---|---|
| EP (2) | EP1244705B1 (de) |
| JP (3) | JP4827357B2 (de) |
| AT (1) | ATE456578T1 (de) |
| AU (2) | AU775366B2 (de) |
| CA (1) | CA2395053C (de) |
| CY (1) | CY1111034T1 (de) |
| DE (1) | DE60043784D1 (de) |
| DK (1) | DK1244705T3 (de) |
| ES (1) | ES2340249T3 (de) |
| IL (3) | IL150018A0 (de) |
| PT (1) | PT1244705E (de) |
| WO (1) | WO2001040276A2 (de) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7037667B1 (en) | 1998-06-01 | 2006-05-02 | Agensys, Inc. | Tumor antigen useful in diagnosis and therapy of prostate and colon cancer |
| US20030149531A1 (en) | 2000-12-06 | 2003-08-07 | Hubert Rene S. | Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| US20060052321A1 (en) | 2002-04-05 | 2006-03-09 | Raitano Arthur B | Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer |
| US20040141975A1 (en) | 1998-06-01 | 2004-07-22 | Raitano Arthur B. | Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer |
| US6833438B1 (en) | 1999-06-01 | 2004-12-21 | Agensys, Inc. | Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| JP4855577B2 (ja) | 1998-06-01 | 2012-01-18 | アジェンシス，インコーポレイテッド | ヒト癌で発現される新規蛇行性膜貫通抗原およびその使用 |
| US7611892B2 (en) | 2000-03-24 | 2009-11-03 | President And Fellows Of Harvard College | Prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| US7189565B2 (en) | 2001-03-23 | 2007-03-13 | Fahri Saatcioglu | Prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| EP1311674A2 (de) * | 2000-08-24 | 2003-05-21 | Genentech, Inc. | Zusammensetzungen und verfahren zur diagnose und behandlung von krebs |
| AU2002336446B2 (en) | 2001-09-06 | 2008-03-06 | Agensys, Inc. | Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer |
| US7494646B2 (en) | 2001-09-06 | 2009-02-24 | Agensys, Inc. | Antibodies and molecules derived therefrom that bind to STEAP-1 proteins |
| CA2481503A1 (en) * | 2002-04-05 | 2003-10-23 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| WO2004016643A2 (en) * | 2002-08-16 | 2004-02-26 | Yeda Research And Development Co. Ltd. | Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccines |
| JP5840351B2 (ja) | 2002-09-06 | 2016-01-06 | アジェンシス，インコーポレイテッド | 癌の処置および検出において有用な９８ｐ４ｂ６と称される、核酸および対応タンパク質 |
| CA2518119A1 (en) * | 2003-03-05 | 2004-09-16 | Innexus Biotechnology Inc. | Trans-membrane-antibody induced inhibition of apoptosis |
| SG10201701737XA (en) | 2003-11-06 | 2017-04-27 | Seattle Genetics Inc | Monomethylvaline compounds capable of conjugation to ligands |
| CN101258166B (zh) | 2004-04-22 | 2013-01-30 | 阿根西斯公司 | 与steap-1蛋白结合的抗体及其衍生的分子 |
| AU2005246090A1 (en) * | 2005-02-22 | 2005-12-01 | Biomedisinsk Innovasjon As | STAMP2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| JP4191189B2 (ja) | 2005-12-08 | 2008-12-03 | 康生 梅津 | がん関連遺伝子活性化能を有するペプチド |
| AU2007284651B2 (en) * | 2006-08-09 | 2014-03-20 | Institute For Systems Biology | Organ-specific proteins and methods of their use |
| SI2502938T1 (sl) | 2006-10-27 | 2015-05-29 | Genentech, Inc. | Protitelesa in imunokonjugati in njihove uporabe |
| JP5394246B2 (ja) * | 2007-03-30 | 2014-01-22 | ジェネンテック， インコーポレイテッド | 抗体及びイムノコンジュゲートとこれらの使用方法 |
| PE20090481A1 (es) | 2007-07-16 | 2009-05-18 | Genentech Inc | Anticuerpos anti-cd79b e inmunoconjugados humanizados y metodos de uso |
| PL2474557T3 (pl) | 2007-07-16 | 2015-02-27 | Genentech Inc | Przeciwciała anty- CD79b i immunokoniugaty i sposoby stosowania |
| WO2009046739A1 (en) | 2007-10-09 | 2009-04-16 | Curevac Gmbh | Composition for treating prostate cancer (pca) |
| PT2247620T (pt) | 2008-01-31 | 2016-08-23 | Genentech Inc | Anticorpos e imunoconjugados anti-cd79b e métodos de utilização |
| WO2010037408A1 (en) | 2008-09-30 | 2010-04-08 | Curevac Gmbh | Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof |
| WO2014165818A2 (en) | 2013-04-05 | 2014-10-09 | T Cell Therapeutics, Inc. | Compositions and methods for preventing and treating prostate cancer |
| AU2015320678B2 (en) | 2014-09-23 | 2021-07-22 | Genentech, Inc. | Method of using anti-CD79b immunoconjugates |
| US9879087B2 (en) | 2014-11-12 | 2018-01-30 | Siamab Therapeutics, Inc. | Glycan-interacting compounds and methods of use |
| FI3218005T3 (fi) | 2014-11-12 | 2023-03-31 | Seagen Inc | Glykaanin kanssa vuorovaikutteisia yhdisteitä ja käyttömenetelmiä |
| CN108463248B (zh) | 2015-11-12 | 2022-10-21 | 西雅图基因公司 | 聚糖相互作用化合物及使用方法 |
| AU2017331361B2 (en) * | 2016-09-23 | 2024-07-18 | Regeneron Pharmaceuticals, Inc. | Anti-STEAP2 antibodies, antibody-drug conjugates, and bispecific antigen-binding molecules that bind STEAP2 and CD3, and uses thereof |
| EP3541847A4 (de) | 2016-11-17 | 2020-07-08 | Seattle Genetics, Inc. | Glycaninteragierende verbindungen und verfahren zur verwendung |
| JP2020510671A (ja) | 2017-03-03 | 2020-04-09 | シアトル ジェネティックス， インコーポレイテッド | グリカン相互作用化合物および使用の方法 |
| MA49289A (fr) | 2017-04-03 | 2020-02-12 | Hoffmann La Roche | Anticorps se liant à steap-1 |
| WO2019125184A1 (en) | 2017-12-19 | 2019-06-27 | Auckland Uniservices Limited | Use of biomarker in cancer therapy |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5489525A (en) * | 1992-10-08 | 1996-02-06 | The United States Of America As Represented By The Department Of Health And Human Services | Monoclonal antibodies to prostate cells |
| US5919652A (en) | 1994-11-09 | 1999-07-06 | The Regents Of The University Of California | Nucleic acid molecules comprising the prostate specific antigen (PSA) promoter and uses thereof |
| AU5243198A (en) * | 1996-10-30 | 1998-05-22 | Uab Research Foundation, The | Enhancement of tumor cell chemosensitivity and radiosensitivity using single chain intracellular antibodies |
| US6048970A (en) * | 1998-05-22 | 2000-04-11 | Incyte Pharmaceuticals, Inc. | Prostate growth-associated membrane proteins |
| JP4855577B2 (ja) * | 1998-06-01 | 2012-01-18 | アジェンシス，インコーポレイテッド | ヒト癌で発現される新規蛇行性膜貫通抗原およびその使用 |
| EP1140970A4 (de) * | 1998-12-17 | 2003-10-22 | Human Genome Sciences Inc | 47 menschliche sekretierte proteine |
| US20020015950A1 (en) * | 1999-07-07 | 2002-02-07 | Karen Anne Jones | Atherosclerosis-associated genes |
| AU6906800A (en) * | 1999-08-17 | 2001-03-13 | Incyte Genomics, Inc. | Membrane associated proteins |
-
2000
- 2000-12-06 DE DE60043784T patent/DE60043784D1/de not_active Expired - Lifetime
- 2000-12-06 AT AT00983938T patent/ATE456578T1/de active
- 2000-12-06 AU AU20629/01A patent/AU775366B2/en not_active Expired
- 2000-12-06 CA CA2395053A patent/CA2395053C/en not_active Expired - Lifetime
- 2000-12-06 PT PT00983938T patent/PT1244705E/pt unknown
- 2000-12-06 ES ES00983938T patent/ES2340249T3/es not_active Expired - Lifetime
- 2000-12-06 WO PCT/US2000/033040 patent/WO2001040276A2/en active Application Filing
- 2000-12-06 EP EP00983938A patent/EP1244705B1/de not_active Expired - Lifetime
- 2000-12-06 DK DK00983938.2T patent/DK1244705T3/da active
- 2000-12-06 EP EP05014435A patent/EP1642909A3/de not_active Withdrawn
- 2000-12-06 JP JP2001541031A patent/JP4827357B2/ja not_active Expired - Lifetime
- 2000-12-06 IL IL15001800A patent/IL150018A0/xx unknown
-
2002
- 2002-06-04 IL IL150018A patent/IL150018A/en active IP Right Grant
-
2004
- 2004-10-29 AU AU2004224964A patent/AU2004224964B2/en not_active Expired
-
2005
- 2005-12-19 JP JP2005365540A patent/JP2006204290A/ja not_active Withdrawn
-
2009
- 2009-06-10 IL IL199275A patent/IL199275A0/en active IP Right Grant
-
2010
- 2010-04-26 CY CY20101100373T patent/CY1111034T1/el unknown
- 2010-09-22 JP JP2010212334A patent/JP2011062201A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| PT1244705E (pt) | 2010-05-04 |
| EP1244705B1 (de) | 2010-01-27 |
| JP2011062201A (ja) | 2011-03-31 |
| CA2395053A1 (en) | 2001-06-07 |
| AU2062901A (en) | 2001-06-12 |
| AU2004224964B2 (en) | 2008-10-02 |
| JP2006204290A (ja) | 2006-08-10 |
| EP1244705A2 (de) | 2002-10-02 |
| CA2395053C (en) | 2012-05-29 |
| AU775366B2 (en) | 2004-07-29 |
| WO2001040276A2 (en) | 2001-06-07 |
| AU2004224964A1 (en) | 2004-11-25 |
| CY1111034T1 (el) | 2015-08-05 |
| WO2001040276A3 (en) | 2002-01-10 |
| IL150018A0 (en) | 2002-12-01 |
| IL199275A0 (en) | 2011-07-31 |
| IL150018A (en) | 2011-04-28 |
| JP2003517306A (ja) | 2003-05-27 |
| EP1642909A2 (de) | 2006-04-05 |
| EP1642909A3 (de) | 2006-04-12 |
| DE60043784D1 (de) | 2010-03-18 |
| DK1244705T3 (da) | 2010-05-31 |
| JP4827357B2 (ja) | 2011-11-30 |
| ES2340249T3 (es) | 2010-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE456578T1 (de) | Serpentinetransmembranrezeptoren exprimiert in menschlichem prostatakrebs und ihre verwendungen | |
| DE69941187D1 (de) | Serpentintransmembranantigene exprimiert in menschlichem krebs und deren verwendungen | |
| Südhof et al. | Cassette of eight exons shared by genes for LDL receptor and EGF precursor | |
| BR0009964A (pt) | Peptìdios artificiais com atividade desuperfìcie e sua utilização na preparação de surfactante artificial | |
| BR0108711A (pt) | Expressão heteróloga de proteìnas de neisseria | |
| RU2002124123A (ru) | Модифицированный фактор viii | |
| DE60039752D1 (de) | Herstellung tetravalenter antikörper | |
| DE69926647D1 (de) | Durch molekulares pathogenicid vermittelte krankheitsresistenz in pflanzen | |
| FR2649982B1 (fr) | Membrane biologique artificielle | |
| ES2060803T3 (es) | Soporte biologico para cultivos celulares constituido por proteinas plasmaticas coaguladas por trombina, su utilizacion para el cultivo de los queratinocitos, su recuperacion y su transporte con fines de utilizacion terapeutica. | |
| TR200002695T2 (tr) | Viral zar proteinlerdeki epitoplar ve bu epitoplara karşı yönlenmiş özel antikorlar: ev sahibi dokuda viral HCV antijenlerinin tespiti için kullanılması. | |
| ES2123973T3 (es) | Afamina: una proteina similar a la seroalbumina humana. | |
| CN103068844A (zh) | 视黄醇改性胶原、其制备方法和含有其的皮肤外用组合物 | |
| NO971341L (no) | Promoter for reseptor tyrosinkinase TIE | |
| DE60226896D1 (de) | Herstellung von f(ab')2 fragmenten in saügetierzelle | |
| BR0012704A (pt) | Anticorpos antitumor, proteìnas e usos dos mesmos | |
| BR0113623A (pt) | Proteìnas sintéticas de estìmulo da eritropoiese | |
| DE602004031886D1 (de) | Auf öligen substanzen basierte körperreinigungzubereitung | |
| Yamamoto et al. | The Dansyl Group as a Molecular Probe for the Histochemical Localization of a Synthetic Fibronectin-related Peptide. | |
| ATE260339T1 (de) | Antikörper gegen menschliches restrictin | |
| RU2002129171A (ru) | Рекомбинантный аттенуированный штамм бактерий salmonella enteriditis е-23/pgex-2t-tbi как кандидат для конструирования живой вакцины против вируса иммунодефицита человека | |
| IL150045A0 (en) | Compositions and methods for detecting stress-inducible proteins | |
| BR9811531A (pt) | Preparação de proteìnas mutadas humanas em células humanas por meio de recombinação homóloga |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1244705 Country of ref document: EP |